Via ECDC: Joint ECDC-WHO Regional Office for Europe Monkeypox Surveillance Bulletin. The summary:
A total of 15926 cases of monkeypox have been identified through IHR mechanisms and official public resources up to 2 August 2022, 14:00, from 38 countries and areas throughout the European region. Case-based data were reported for 15624 cases from 32 countries and areas to ECDC and the WHO Regional Office for Europe through The European Surveillance System (TESSy), up to 2 August 2022, 10:00.
Of the 15624 cases reported in TESSy, 15524 were laboratory confirmed. Furthermore, where sequencing was available, 203 were confirmed to be of the West African clade.
The earliest date of symptom onset was reported as 11 March 2022. The majority of cases were between 31 and 40 years-old (6349/15595 - 41%) and male (15439/15572 - 99.1%). Among cases with known HIV status, 36% (2690/7487) were HIV-positive. The majority of cases presented with a rash (9126/9626 - 94.8%) and systemic symptoms such as fever, fatigue, muscle pain, chills, or headache (6300/9626 - 65%).
399 cases were hospitalised (5.6%), of which 150 cases required clinical care. Three cases were admitted to ICU, among whom one was admitted to ICU for reasons unrelated to monkeypox infection. The two other cases admitted to ICU were reported to have died of monkeypox.
Some (41) cases were reported to be health workers, however no occupational exposure has been reported.
